Free for healthcare professionals from around the world, this event offers a unique opportunity to gain expert insights and exchange knowledge.

The series will run every 3 weeks from May 8 to July 10, 2021. Through presentations from dermatology experts, it will highlight the impact of essential COVID-19 mask wearing on skin health, including for acne and rosacea sufferers.

“Galderma is committed to providing premium expert-led education that is focused on the needs of the dermatology community. I am delighted to announce the launch of Galderma’s new GEMME platform, featuring unique insights from dermatology experts worldwide. We are beginning with a particularly timely topic, the specific challenges COVID-19 has caused for healthcare providers and patients living with dermatological diseases.”

— Dr Baldo Sforzolini, Global Head of Research and Development

Each webinar will offer an interactive experience through live Q&A sessions with dermatology experts. 

Unmasking Facial Skin & Dermatoses Webinars:

• Webinar 1 on Saturday May 8: Under the mask: the consequences of essential mask wearing
• Webinar 2 on Saturday May 29: Mask wearing and Rosacea: protection or trigger?
• Webinar 3 on Saturday June 19: Zooming on ‘mAsKNE’: more than a trend
• Webinar 4 on Saturday July 10: Under the mask: protecting the barrier that matters

“This webinar series will support healthcare providers in tackling issues arising from essential mask wearing on skin health in clinical practice. It will help to address patient needs and raise interest in the development of new guidelines and research. There is a lot of knowledge to be gained from the current pandemic, including how to mitigate the consequences of mask wearing on facial skin diseases. We are excited to share our knowledge and learnings with the healthcare community to support ongoing improvement in patient outcomes.”

— Prof Dr Jerry Tan, webinar series chair and adjunct professor, Western University, Ontario, Canada

[Source(s): Galderma, PR Newswire]

Astanza Laser, the leading distributor of laser technology for tattoo removal, hair removal, and other aesthetic treatments, is excited to host a free webinar with renowned physician and dermatologist Dr. Jason Emer called Dr. Jason Emer Talks Advanced Laser Hair Removal for Med Spas. Dr. Jason Emer is an award-winning, board-certified physician who has gained national recognition for the innovative aesthetic solutions he provides at his Beverly Hills practice.

The Dr. Jason Emer Talks Advanced Laser Hair Removal for Med Spas webinar is free to view upon registration and will stream live on Monday, December 14, 2020, at 10:00 am CST.

Read the full article at tylerpaper.com

During the free webinar, PPD experts Rose Blackburne, MD, MBA, Executive Medical Director, Global Product Development; Norma Cantu, Senior Director, Project Management; and John Manns, Senior Director, Innovation and Digital Operations, will discuss the incorporation of digital options for dermatology trials and how to increase the speed and quality of data.

In addition, they will discuss how a decentralized trial design benefits each stakeholder, as well as highlight strategies to compete for eligible and diverse patient populations.

[Source(s): Xtalks, PRWeb]

The event, “Motiva: A Decade of Contributions to Women’s Health,” will take place October 21 from 2 pm to 3pm EST.

It will feature presentations by members of the Company’s Medical Advisory Board, Scientific Advisory Board and independent plastic surgeons who will speak about their clinical data and long-term experiences using the Company’s innovative products.

Panel members scheduled to participate include Brian Kinney, MD, FACS; Prof. Marcos Sforza, MD; Dennis Hammond, MD, FACS; Charles Randquist, MD; Giovanni Botti, MD; and Manuel Chacón, MD.  The symposium will also include remarks by Caroline Glicksman, MD, FACS, Medical Director for the Motiva Implants U.S. clinical trial, which is studying the safety and effectiveness of the Motiva Implants SmoothSilk Round and Ergonomix silicone gel-filled breast implants in augmentation, reconstruction and revision surgery.

[Source(s): Establishment Labs Holdings Inc, Globe Newswire]

Related Content:
Study Details New Advancements in Hybrid Breast Reconstruction Technique Using Motiva Ergonomix Implants

“We’re excited to virtually participate at the ASDS meeting and share several data presentations from our leading treatment portfolio, which include findings on Xeomin’s safety and prolonged duration of effect in a dose-ranging study,” said Terri Phillips, MD, chief medical affairs officer, Merz Aesthetics.

The following presentations will also be shared virtually at the ASDS meeting. Products mentioned below have not been studied in combination use by Merz Aesthetics.

ORAL LATE-BREAKING SESSION

• IncobotulinumtoxinA demonstrates safety and prolonged duration of effect in a dose-ranging study for glabellar lines; Michael H. Gold, MD
  Sunday, October 11, 10:45 am to 10:48 am (ET)

This manuscript was also recently published in the October issue of the peer-reviewed Journal of Drugs and Dermatology (JDD). 

ORAL ABTRACTS SESSIONS

• Is it possible to interfere in the eyebrow shape and positioning while injecting Incobotulinumtoxin A into the brow depressors and also the frontalis?; Carla Pecora, MD
  Saturday, October 10, 11:09 am to 11:12 am
• Adaptation of Face Attractiveness; Kate Goldie, MD
  Sunday, October 11, 10:36 am to 10:39 am

Scientific ePosters will be viewable by attendees for the duration of the meeting beginning on Friday, October 9 until Sunday, October 11. Presentations include:

• Calcium hydroxylapatite microspheres provide organization into unorganized collagen networks leading to improvement of skin attractiveness; Gabriela R. Casabona, MD
• B.UP technique: safety assessment, effectiveness and satisfaction: Report 10 cases; Rossana Vasconcelos, MD
• Changing the architecture of the midface; Kate Goldie, MD

In this free webinar, the featured speakers will discuss concepts such as adverse event photography, where patients can capture photos of a possible adverse reaction onset and rapidly share them with the study site for review and appropriate identification.

Attendees will learn how to align simplicity with cost efficiencies by using compact photo documentation solutions and how patients can securely submit images using their own device, following guidelines to ensure standardization of the images for review.

For more information or to register for this event, visit Xtalks.

[Source(s): Xtalks, PRWeb]

New treatment options for moderate to severe dermatological diseases and areas of high unmet need are driving a revolution in clinical development of dermatology drugs. But questions remain: What indications should be pursued? How to design a study that targets the right endpoints? And how will environmental constraints affect the research?

This webinar will explore dermatology trials from the vantage point of study design, patient access, data quality, regulatory considerations, and more. Panelists will discuss what’s required to understand the disease burden, patients’ treatment goals, and critical elements in devising effective recruitment and retention strategies.

Click here to view original web page at www.prweb.com